Patient Preference, Sleep Quality, and Anxiety/Depression: A Randomized Comparison of Raltegravir and Efavirenz.

Trial Profile

Patient Preference, Sleep Quality, and Anxiety/Depression: A Randomized Comparison of Raltegravir and Efavirenz.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Efavirenz (Primary) ; Raltegravir (Primary)
  • Indications HIV infections
  • Focus Adverse reactions
  • Acronyms SWITCH-ER
  • Most Recent Events

    • 17 May 2011 Results published in the AIDS.
    • 13 Jan 2010 Actual initiation date (Nov 2009) added as reported by ClinicalTrials.gov.
    • 13 Jan 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top